NHIS

Treatments for childhood cancers, as well as the cost of Hydroxyurea, an essential drug for the treatment of sickle cell anaemia, are now covered by the National Health Insurance Scheme (NHIS), Vice President Mahamudu Bawumia has announced. Announcing this on Thursday, 25th August, 2022 in Accra, Vice President Bawumia disclosed that reimbursement of childhood cancers under NHIS became effective 1st July 2022, and plans are far advanced to add treatment for other forms of cancer to the list of ailments covered by NHIS. “We have started with four cancers amongst children for now but we are determined to expand in…